Adrenal cortical hyperplasia which is known to occur during infection and after trauma (1, 2) suggests the occurrence of a corresponding increase in the physiological activity of the gland. Scant information is available, however, bearing directly on the functional status of the adrenal cortex during conditions of stress. It would be important to know not only whether periods of stress are accompanied by increased cortical function, but also whether recovery might be influenced by the functional state of the adrenal cortex, and whether such conditions as post-infectious asthenia might be attributable to adrenal exhaustion resulting from extreme stimulation during the active phase of the-disease.
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Although the excretion of neutral 17-ketosteroids is influenced by adrenal cortical function, the chemical determination of these steroids affords a poor measure of the activity of the gland, inasmuch as the adrenal is not the sole source of the compounds in this fraction. Moreover, information as to the precursors of urinary 17-ketosteroids is far from complete. The one classical precursor, testosterone, has insignificant cortinlike activity.
Browne and coworkers demonstrated the presence of cortin-like activity in the urine of postoperative patients and patients suffering infection or other types of stress, but were not able to detect the material in normal urine (3a and b). Evidence has recently been adduced that the substance is present in the urine of normal men and women who have not been subjected to stress, and that it possesses the physiological properties of cortical hormone when tested by a great variety of methods (4 to 9). Furthermore, the material has been ob- I served to disappear from the urine of monkeys after adrenalectomy, but not after gonadectomy (10) , and activity has not been detectable in the urine of patients with Addison's disease (11) . It may therefore be assumed with justification that the urinary substance has its origin in the adrenal cortex, and that its rate of excretion should be influenced by variations in cortical function.
The intent of the work herein reported was to determine the urinary cortin output of human subjects in the normal state, during stress, and during recovery from stress. It was considered desirable to employ methods which would allow expression of cortin values in terms of a pure cortical hormone, rather than as arbitrary biological units. These studies are a part of a broader investigation of the physiology and chemistry of active urinary cortical hormones.
METHODS
Preparation of extracts. Urine samples were collected in 48-hour lots, and were preserved with toluene. The pH varied from approximately 5.5 to 6.5. One-fourth volume of ethylene dichloride was added, and after being shaken for 2 minutes in a mechanical shaker, the ethylene dichloride was separated from the urine with a Sharples centrifuge. The urine was extracted twice more with the same volume of ethylene dichloride and the 3 extracts pooled and evaporated in vacuo at an internal temperature below 400 C. After twice adding 95 per cent ethanol and evaporating to dryness to remove residual ethylene dichloride, the residue was taken up in 50 ml. chloroform, cooled in an ice bath and washed 3 times with 0.1 N NaOH. Each washing of NaOH was backwashed with 5 ml. of chloroform. All chloroform fractions were pooled and washed with 5 ml. H20 4 the others received urinary extract in doses equivalent to from ¼4 to 1 hour of urine output. Each urine sample was administered at a minimum of 2 different dose levels. If the group receiving compound A survived at least 20 per cent longer than the control group, and if the 2 dose levels of urine extract followed a rising curve, the results were considered satisfactory for calculation of potency ( Figure 1 ). Inasmuch as the sensitivity of various lots of animals is variable, the slope of the response curve is likewise variable, and the error of an assay cannot be predicted in advance. When 2 dose levels of unknown are used, and when sensitivity is maximal, the limits of error are M as great, or 3 times greater than the observed value with p = 0.05. When sensitivity is at the lowest accepted level (20 per cent increase to 64 r of compound A) these limits are Ye and 6. Inasmuch as the slope, furthermore, must be estimated for each assay, it is clear that values which were obtained by the cold test method were rough estimations.
The glycogen test as employed for assay is about Y4 as sensitive as the cold test, and is rather laborious, but is more reproducible and subject to less error. There is a long rising portion of the log-dose response curve without a decline at higher dose levels, and there is no indication of a lack of sensitivity of animals from group to group.
In the use of this assay, 8 to 10 mice received a given dose of urine extract (usually 3 hours of urine equivalent). The mouse livers were pooled and the glycogen content of the pooled sample determined. Potency of an extract was estimated by reference to a standard curve obtained by the administration of graded doses of compound A (l1-dehydrocorticosterone) to a series of 193 mice. The usual limits of error of an assay (p = 0.05) were calculated to be 3 times higher, or % as great as the observed value (error factor of 3).
RESULTS
The cortin content of normal urine. A pooled sample of male urine (N-197), when assayed against compound A, gave a value of 0.6 mgm. per liter by the cold test, and 0.4 mgm. by the glycogen test. The error factor of the latter was 1.6 with p = 0.05, and 1.9 with p = 0.01. The assay curves of compound A and pooled normal urine are illustrated in Figure 2 . The details of these comparisons are recorded elsewhere (12, 13) .
In Table I t Liver glycogen test.
The febrile period was defined as the active phase of the disease; the first week after fever subsided was considered to be the phase of early convalescence; and the second week, late convalescence. Urinary cortin as influenced by infection. Seven patients with infectious disease were studied. The findings are tabulated in Table II . Five of the patients showed increases in excretion during the febrile, or early post-febrile stages, which were higher than levels encountered in normal subjects. The 2 patients which showed no augmentation in output were ill for only 1 (Table III) . Assays were done on patient C. D. for a 48-hour period at home before admission to the hospital, and for another 48 hours pre-operatively while he was confined to bed. An ambulatory control period was not included in the case of patient J. W. In both cases there was a distinct rise in excretion during the first 2 to 4 days post-operatively. Patient J. W. showed an increase more than 10-fold above his pre-operative level. After 6 days the levels in both cases had returned to normal. There were no post-operative complications. It should be noted that patient C. D. received a local anesthetic, and that the response in this instance may therefore be attributed to the surgical procedure per se.
Cortin excretion after body burns. This group included 3 patients ( Table IV) . The 1 patient (M. D.) who recovered was studied over a fairly long period of convalescence. There was an unmistakable rise in cortin excretion during the first 8 days after the burn. By the end of 12 days the elevation was less marked, and beyond 12 days the values had declined to within the range of normal. Patient C. D. showed a moderate elevation shortly before his death on the ninth day. Patient A. T., who also died, did not excrete quantities of cortin in excess of the values normally encountered.
The results herein reported confirm and extend the original findings of Weil and Browne. Venning and Browne (14) , furthermore, have recently demonstrated a rise in urinary cortin during stress when assays were performed by a glycogen method. Our most formidable hurdle has been the development of quantitative assay methods possessing sufficient simplicity and reliability to be applied to clinical cases. Methods which are now available still leave much to be desired. It is possible, however, that further refinement of the glycogen procedure will render it reasonably satisfactory for this purpose. Talbot and coworkers (15) It is reasonable to assume that the increased cortin output during stress is a reflection of increased cortical hormone production. Other possible interpretations are a decreased tissue affinity for the hormone, an increase in the rate of renal excretion, or a decreased inactivation. It is unlikely that decreased tissue affinity or increased excretion could be responsible for the augmented output. The possibility of decreased inactivation could be more easily defended, however.
Adrenal cortical hypersecretion would fit very nicely into the pattern of physiological readjustment which is known to result from the stimulus of stress. Selye was the first to emphasize that the organism reacts in identical fashion to a variety of damaging stimuli (16) . He emphasized, moreover, that the adrenal cortex was probably of prime importance in the facilitation of adjustment. In order to simplify discussion, some of the possible physiological and clinical implications of cortical hyperfunction during stress are outlined in tabular form (Table V) . Albright (17) has recently discussed a number of these mechanisms.
If one assumes that increased cortical secretion during stress is beneficial to the organism, it follows that any failure in this function should influence the course of recovery. If it can be shown that in some cases of infection or other stress a low output of cortin is associated with a higher mortality or a delay in recovery, it would be justifiable to administer cortical hormone to such patients. Such a correlation has as yet not been made, however, and evidence does not exist that in the absence of specific adrenal disease hypo- 1. In normal subjects the daily excretion of urinary cortin averaged about 1.1 mgm. of compound A-equivalent per day when assayed biologically by a cold protection test, and < 0.4 mgm. per day by a glycogen deposition test. There was no obvious difference in the output of male and female subjects.
2. In the presence of infectious disease, after body burns, and during the first 2 days after herniorrhaphy, the output of urinary cortin was usually increased above the control levels. The rise in some instances was as high as 10-fold.
3. During recovery from stress there was no abnormal depression in output which one would expect in the presence of adrenal exhaustion.
